These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

131 related items for PubMed ID: 2457543

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Posttrauma coagulation and fibrinolysis.
    Gando S, Tedo I, Kubota M.
    Crit Care Med; 1992 May; 20(5):594-600. PubMed ID: 1533358
    [Abstract] [Full Text] [Related]

  • 24. Fibrinopeptide A and fibrinopeptide B beta 15-42 in patients with Behçet's disease.
    Sunakawa M, Okinami S.
    Metab Pediatr Syst Ophthalmol (1985); 1988 May; 11(4):147-8. PubMed ID: 3221795
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. [Coagulation-fibrinolysis abnormalities in acute stage hypertensive intra-cerebral hemorrhage and head injury (preliminary report). With special reference to fibrinopeptides A and B beta 15-42].
    Touho H, Hino A, Suzuki K, Kubo S, Hirakawa K.
    Neurol Med Chir (Tokyo); 1985 Mar; 25(3):203-8. PubMed ID: 2409465
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Increased fibrin/fibrinogen degradation products without increase of plasmin-alpha 2-plasmin inhibitor complex after hepatectomy for hepatocellular carcinoma.
    Takeda S, Katoh H, Takaki A, Okamoto K, Ohsato K.
    Thromb Res; 1990 Jan 15; 57(2):289-300. PubMed ID: 2156347
    [Abstract] [Full Text] [Related]

  • 30. Activation of coagulation and fibrinolytic systems following stroke.
    Lane DA, Wolff S, Ireland H, Gawel M, Foadi M.
    Br J Haematol; 1983 Apr 15; 53(4):655-8. PubMed ID: 6219694
    [Abstract] [Full Text] [Related]

  • 31. Induction of marked thrombin activity by pharmacologic concentrations of plasminogen activators in nonanticoagulated whole blood.
    Eisenberg PR, Miletich JP.
    Thromb Res; 1989 Sep 01; 55(5):635-43. PubMed ID: 2510363
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. [Approach of hematology. Abnormal findings of coagulation and fibrinolytic factors in DIC].
    Ikematsu S, Kato M, Kuroso K.
    Rinsho Byori; 1984 Aug 01; 32(8):862-8. PubMed ID: 6502985
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Subclinical activation of fibrinolysis in atherosclerotic disease detected by B beta 15-42 assay.
    Marongiu F, Mamusa AM, Mameli G, Conti M, Sorano GG, Biondi G, Farci P, Balestrieri A.
    Ric Clin Lab; 1989 Aug 01; 19(2):157-63. PubMed ID: 2528202
    [Abstract] [Full Text] [Related]

  • 36. [An analysis of DIC in patients with multiple organ failure--variations of the molecular makers and its clinical usefulness].
    Gando S, Tedo I.
    Rinsho Ketsueki; 1990 Nov 01; 31(11):1774-9. PubMed ID: 2149574
    [Abstract] [Full Text] [Related]

  • 37. Fibrinopeptide A and the phosphate content of fibrinogen in venous thromboembolism and disseminated intravascular coagulation.
    Leeksma OC, Meijer-Huizinga F, Stoepman-van Dalen EA, van Ginkel CJ, van Aken WG, van Mourik JA.
    Blood; 1986 May 01; 67(5):1460-7. PubMed ID: 3697510
    [Abstract] [Full Text] [Related]

  • 38. Fibrinopeptide A levels indicative of pulmonary vascular thrombosis in patients with primary pulmonary hypertension.
    Eisenberg PR, Lucore C, Kaufman L, Sobel BE, Jaffe AS, Rich S.
    Circulation; 1990 Sep 01; 82(3):841-7. PubMed ID: 2394005
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.